Stephanie DeArmey

752 total citations
9 papers, 390 citations indexed

About

Stephanie DeArmey is a scholar working on Physiology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Stephanie DeArmey has authored 9 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Rheumatology and 3 papers in Psychiatry and Mental health. Recurrent topics in Stephanie DeArmey's work include Lysosomal Storage Disorders Research (6 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Child Nutrition and Feeding Issues (3 papers). Stephanie DeArmey is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Child Nutrition and Feeding Issues (3 papers). Stephanie DeArmey collaborates with scholars based in United States, Taiwan and France. Stephanie DeArmey's co-authors include Priya S. Kishnani, Sarah P. Young, Jennifer S. Li, Sue Ann Smith, James H. Heller, Dwight D. Koeberl, Amy S. Rosenberg, Hanna Mandel, Paula Goldenberg and Danny Benjamin and has published in prestigious journals such as International Journal of Molecular Sciences, Genetics in Medicine and Molecular Genetics and Metabolism.

In The Last Decade

Stephanie DeArmey

9 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie DeArmey United States 5 309 179 105 89 83 9 390
Toju Tanaka Japan 10 274 0.9× 106 0.6× 121 1.2× 101 1.1× 43 0.5× 16 417
Ankit K. Desai United States 12 415 1.3× 249 1.4× 106 1.0× 105 1.2× 111 1.3× 30 503
Ana Marcão Portugal 12 402 1.3× 160 0.9× 169 1.6× 188 2.1× 128 1.5× 22 616
Jessica de Ruijter Netherlands 8 333 1.1× 91 0.5× 162 1.5× 68 0.8× 64 0.8× 11 405
Masahisa Kobayashi Japan 15 427 1.4× 114 0.6× 212 2.0× 113 1.3× 122 1.5× 38 564
Maja Djordjevic Serbia 11 121 0.4× 68 0.4× 60 0.6× 118 1.3× 37 0.4× 40 360
Suresh Vijay United Kingdom 9 252 0.8× 79 0.4× 102 1.0× 68 0.8× 29 0.3× 31 337
Chuan‐Hong Kao Taiwan 7 204 0.7× 102 0.6× 103 1.0× 158 1.8× 50 0.6× 10 411
Christine Broissand France 7 175 0.6× 66 0.4× 82 0.8× 138 1.6× 23 0.3× 10 416
François Eyskens Belgium 8 153 0.5× 65 0.4× 54 0.5× 72 0.8× 44 0.5× 17 292

Countries citing papers authored by Stephanie DeArmey

Since Specialization
Citations

This map shows the geographic impact of Stephanie DeArmey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie DeArmey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie DeArmey more than expected).

Fields of papers citing papers by Stephanie DeArmey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie DeArmey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie DeArmey. The network helps show where Stephanie DeArmey may publish in the future.

Co-authorship network of co-authors of Stephanie DeArmey

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie DeArmey. A scholar is included among the top collaborators of Stephanie DeArmey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie DeArmey. Stephanie DeArmey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jung, Seung‐Hye, et al.. (2022). Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. International Journal of Molecular Sciences. 23(23). 14938–14938. 2 indexed citations
2.
Case, Laura E., Stephanie DeArmey, Harrison N. Jones, et al.. (2020). Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature. Genetics in Medicine. 22(5). 898–907. 40 indexed citations
3.
ElMallah, Mai K., et al.. (2020). Pulmonary outcome measures in long‐term survivors of infantile Pompe disease on enzyme replacement therapy: A case series. Pediatric Pulmonology. 55(3). 674–681. 11 indexed citations
4.
DeArmey, Stephanie, et al.. (2017). Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy. Molecular Genetics and Metabolism Reports. 12. 82–84. 5 indexed citations
5.
Mori, Mari, Stephanie DeArmey, Thomas J. Weber, & Priya S. Kishnani. (2016). Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teeth. Bone Reports. 5. 228–232. 44 indexed citations
6.
Berrier, Kathryn L., Zoheb B. Kazi, Stephanie DeArmey, et al.. (2015). Discordant clinical responses in CRIM-positive IPD siblings demonstrate need for prophylactic ITI in the naive setting. Molecular Genetics and Metabolism. 114(2). S22–S22. 1 indexed citations
7.
Banugaria, Suhrad G., Sean N. Prater, Trusha Patel, et al.. (2013). Approach to management of cross-reactive immunologic material (CRIM)-negative infantile pompe patients treated with ERT: Role of immune modulation in changing the natural history. Molecular Genetics and Metabolism. 108(2). S23–S23. 1 indexed citations
8.
Barker, Piers, Michael J. Campbell, Jennifer Li, et al.. (2010). MRI assessment of left ventricular structure and function in children with infantile Pompe disease. Journal of Cardiovascular Magnetic Resonance. 12(S1). 1 indexed citations
9.
Kishnani, Priya S., Paula Goldenberg, Stephanie DeArmey, et al.. (2009). Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Molecular Genetics and Metabolism. 99(1). 26–33. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toju Tanaka Breakdown of academic impact, for papers by Ankit K. Desai Breakdown of academic impact, for papers by Ana Marcão Breakdown of academic impact, for papers by Jessica de Ruijter Breakdown of academic impact, for papers by Masahisa Kobayashi Breakdown of academic impact, for papers by Maja Djordjevic Breakdown of academic impact, for papers by Suresh Vijay Breakdown of academic impact, for papers by Chuan‐Hong Kao Breakdown of academic impact, for papers by Christine Broissand Breakdown of academic impact, for papers by François Eyskens
Rankless by CCL
2026